CLINICAL_TRIALS trial_result · 2014-01-31

Clinical Trial Update: A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema [Phase 3]

Phase 3 trial update evaluating 7.5 mg OPC-41061 in hepatic edema due to cirrhosis; the study completed and results were posted in January 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Cirrhosis | Phase 3 | Status: COMPLETED | Results posted: 2014-01-31